Market

European Pharma Giants Face Stock Plunge After Trump's Tariff Threat on Pharmaceuticals

Market Reacts to Trump's Tariff Announcement

In a significant market movement, stocks of leading European pharmaceutical companies experienced a sharp decline. This reaction followed US President Donald Trump's announcement of imposing a "major tariff" on pharmaceuticals, stirring concerns among investors worldwide.

Impact on Major Pharma Stocks

By 10:18 am CET, Novartis AG and Roche Holding AG saw their stocks plummet by 7.03% and 5.80%, respectively. Shortly after, at 10:32 am CET, Sanofi SA's stocks fell by 5.64%. Similarly, AstraZeneca PLC and GSK plc were not spared, with their stocks sliding by 6.27% and 5.74%, respectively.

Investor Concerns Grow

The announcement has led to growing concerns among investors about the potential ripple effects on the global pharmaceutical market, highlighting the interconnectedness of global economies.